Absence of glucose transporter 4 diminishes electrical activity of mouse hearts during hypoxia

Experimental Physiology

Volumn 98, Issue 3, 2013, Pages 746-757

  Sohn, Kwanghyun ^a,b,c   Wende, Adam R ^a   Abel, E Dale ^a   Moreno, Alonso P ^a,b   Sachse, Frank B ^a,b   Punske, Bonnie B ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRODE; EPICARDIUM; FEMALE; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART STRESS; INSULIN RESISTANCE; MOUSE; NONHUMAN;

EID: 84874115671     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2012.070235     Document Type: Article

References (73)

1. Abel ED (2004). Glucose transport in the heart. Front Biosci 9, 201-215.
2. Abel ED (2005). Myocardial insulin resistance and cardiac complications of diabetes. Curr Drug Targets Immune Endocr Metabol Disord 5, 219-226.
3. Abel ED, Kaulbach HC, Tian R, Hopkins JC, Duffy J, Doetschman T, Minnemann T, Boers ME, Hadro E, Oberste-Berghaus C, Quist W, Lowell BB, Ingwall JS & Kahn BB (1999). Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest 104, 1703-1714.
4. Arya DS, Bansal P, Ojha SK, Nandave M, Mohanty I & Gupta SK (2006). Pyruvate provides cardioprotection in the experimental model of myocardial ischemic reperfusion injury. Life Sci 79, 38-44.
5. 2+ current in rat cardiac myocytes. Cardiovasc Res 42, 113-120.
6. Baker LC, Wolk R, Choi BR, Watkins S, Plan P, Shah A & Salama G (2004). Effects of mechanical uncouplers, diacetyl monoxime, and cytochalasin-D on the electrophysiology of perfused mouse hearts. Am J Physiol Heart Circ Physiol 287, H1771-H1779.
7. Balkau B, Jouven X, Ducimetiere P & Eschwege E (1999). Diabetes as a risk factor for sudden death. Lancet 354, 1968-1969.
8. Barth AS & Tomaselli GF (2009). Cardiac metabolism and arrhythmias. Circ Arrhythm Electrophysiol 2, 327-335.
9. +)-ATPase and cardiac glycoside binding. J Clin Invest 57, 341-350.
10. Boudina S & Abel ED (2007). Diabetic cardiomyopathy revisited. Circulation 115, 3213-3223.
11. Bryant NJ, Govers R & James DE (2002). Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 3, 267-277.
12. Cheng Y, Li L, Nikolski V, Wallick DW & Efimov IR (2004). Shock-induced arrhythmogenesis is enhanced by 2, 3-butanedione monoxime compared with cytochalasin D. Am J Physiol Heart Circ Physiol 286, H310-H318.
13. Clow KA, Rodnick KJ, MacCormack TJ & Driedzic WR (2004). The regulation and importance of glucose uptake in the isolated Atlantic cod heart: rate-limiting steps and effects of hypoxia. J Exp Biol 207, 1865-1874.
14. Cook SA, Varela-Carver A, Mongillo M, Kleinert C, Khan MT, Leccisotti L, Strickland N, Matsui T, Das S, Rosenzweig A, Punjabi P & Camici PG (2010). Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. Eur Heart J 31, 100-111.
15. Crestanello JA, Kamelgard J & Whitman GJ (1995). The cumulative nature of pyruvate's dual mechanism for myocardial protection. J Surg Res 59, 198-204.
16. Crestanello JA, Lingle DM, Millili J & Whitman GJ (1998). Pyruvate improves myocardial tolerance to reperfusion injury by acting as an antioxidant: a chemiluminescence study. Surgery 124, 92-99.
17. Cross HR, Clarke K, Opie LH & Radda GK (1995). Is lactate-induced myocardial ischaemic injury mediated by decreased pH or increased intracellular lactate J Mol Cell Cardiol 27, 1369-1381.
18. Curb JD, Rodriguez BL, Burchfiel CM, Abbott RD, Chiu D & Yano K (1995). Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. Circulation 91, 2591-2595.
19. Davey KA, Garlick PB, Warley A & Southworth R (2007). Immunogold labeling study of the distribution of GLUT-1 and GLUT-4 in cardiac tissue following stimulation by insulin or ischemia. Am J Physiol Heart Circ Physiol 292, H2009-H2019.
20. Desrois M, Sidell RJ, Gauguier D, King LM, Radda GK & Clarke K (2004). Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart. Cardiovasc Res 61, 288-296.
21. Dietrich DL & Elzinga G (1992). ATP formation and energy demand in anoxic heart muscle of the rabbit. Am J Physiol Heart Circ Physiol 263, H526-H532.
22. Doenst T, Guthrie PH, Chemnitius JM, Zech R & Taegtmeyer H (1996). Fasting, lactate, and insulin improve ischemia tolerance in rat heart: a comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 270, H1607-H1615.
23. 2+ and proton flux dysregulation. J Mol Cell Cardiol 48, 663-672.
24. Egert S, Nguyen N, Brosius FC 3rd & Schwaiger M (1997). Effects of wortmannin on insulin- and ischemia-induced stimulation of GLUT4 translocation and FDG uptake in perfused rat hearts. Cardiovasc Res 35, 283-293.
25. Fischer Y, Thomas J, Sevilla L, Muñoz P, Becker C, Holman G, Kozka IJ, Palacín M, Testar X, Kammermeier H & Zorzano A (1997). Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations. J Biol Chem 272, 7085-7092.
26. Gibbs EM, Stock JL, McCoid SC, Stukenbrok HA, Pessin JE, Stevenson RW, Milici AJ & McNeish JD (1995). Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J Clin Invest 95, 1512-1518.
27. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr. & Sowers JR (1999). Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100, 1134-1146.
28. Gu K, Cowie CC & Harris MI (1998). Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 21, 1138-1145.
29. Habazettl H, Palmisano BW, Bosnjak ZJ & Stowe DF (1996). Initial reperfusion with 2, 3 butanedione monoxime is better than hyperkalemic reperfusion after cardioplegic arrest in isolated guinea pig hearts. Eur J Cardiothorac Surg 10, 897-904.
30. Huggins CE, Domenighetti AA, Ritchie ME, Khalil N, Favaloro JM, Proietto J, Smyth GK, Pepe S & Delbridge LM (2008). Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper-responsiveness to substrate intervention. J Mol Cell Cardiol 44, 270-280.
31. + pump density in cultured ventricular myocytes. Am J Physiol Heart Circ Physiol 264, H1208-H1214.
32. + gradient in the oxygenated isolated heart: effect of changing the free energy of ATP hydrolysis. Am J Physiol Heart Circ Physiol 285, H2437-H2445.
33. Kettlewell S, Walker NL, Cobbe SM, Burton FL & Smith GL (2004). The electrophysiological and mechanical effects of 2, 3-butane-dione monoxime and cytochalasin-D in the Langendorff perfused rabbit heart. Exp Physiol 89, 163-172.
34. Kraegen EW, Sowden JA, Halstead MB, Clark PW, Rodnick KJ, Chisholm DJ & James DE (1993). Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4. Biochem J 295, 287-293.
35. Kr impairs conduction in guinea pig hearts. J Cardiovasc Electrophysiol 21, 923-929.
36. Larsen AP, Sciuto KJ, Moreno AP & Poelzing S (2012). The voltage-sensitive dye di-4-ANEPPS slows conduction velocity in isolated guinea pig hearts. Heart Rhythm 9, 1493-1500.
37. Laybutt DR, Thompson AL, Cooney GJ & Kraegen EW (1997). Selective chronic regulation of GLUT1 and GLUT4 content by insulin, glucose, and lipid in rat cardiac muscle in vivo. Am J Physiol Heart Circ Physiol 273, H1309-H1316.
38. Liedtke AJ (1981). Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 23, 321-336.
39. Light PE (2006). Familial Wolff-Parkinson-White Syndrome: a disease of glycogen storage or ion channel dysfunction J Cardiovasc Electrophysiol 17(Suppl 1), S158-S161.
40. Littell R, Milliken G, Stroup W, Wolfinger R & Schabenberger O (2006). SAS for Mixed Models, 2nd edn. SAS Institute Inc., Cary, NC .
41. McDonald TF, Hunter EG & MacLeod DP (1971). Adenosinetriphosphate partition in cardiac muscle with respect to transmembrane electrical activity. Pflugers Arch 322, 95-108.
42. McDonald TF & MacLeod DP (1971). Anoxia-recovery cycle in ventricular muscle: action potential duration, contractility and ATP content. Pflugers Arch 325, 305-322.
43. McDonald TF & MacLeod DP (1973). Metabolism and the electrical activity of anoxic ventricular muscle. J Physiol 229, 559-582.
44. MacLeod DP & Daniel EE (1965). Influence of glucose on the transmembrane action potential of anoxic papillary muscle. J Gen Physiol 48, 887-899.
45. MacLeod DP & Prasad K (1969). Influence of glucose on the transmembrane action potential of papillary muscle. Effects of concentration, phlorizin and insulin, nonmetabolizable sugars, and stimulators of glycolysis. J Gen Physiol 53, 792-815.
46. Mallet RT (2000). Pyruvate: metabolic protector of cardiac performance. Proc Soc Exp Biol Med 223, 136-148.
47. Manchester J, Kong X, Nerbonne J, Lowry OH & Lawrence JC Jr. (1994). Glucose transport and phosphorylation in single cardiac myocytes: rate-limiting steps in glucose metabolism. Am J Physiol Endocrinol Metab 266, E326-E333.
48. Morgan HE, Henderson MJ, Regen DM & Park CR (1961). Regulation of glucose uptake in muscle. I. The effects of insulin and anoxia on glucose transport and phosphorylation in the isolated, perfused heart of normal rats. J Biol Chem 236, 253-261.
49. Moriguchi A, Otani H, Yoshioka K, Shimazu T, Fujita M, Okazaki T, Sato D, Kyoi S & Iwasaka T (2010). Inhibition of contractile activity during postconditioning enhances cardioprotection by restoring sarcolemmal dystrophin through phosphatidylinositol 3-kinase. Circ J 74, 2393-2402.
50. Mueckler M (1990). Family of glucose-transporter genes. Implications for glucose homeostasis and diabetes. Diabetes 39, 6-11.
51. Myears DW, Sobel BE & Bergmann SR (1987). Substrate use in ischemic and reperfused canine myocardium: quantitative considerations. Am J Physiol Heart Circ Physiol 253, H107-H114.
52. + channel blockers on the action potential shortening in hypoxic and ischaemic myocardium. Br J Pharmacol 103, 1019-1026.
53. Nonner W, Spalding BC & Hille B (1980). Low intracellular pH and chemical agents slow inactivation gating in sodium channels of muscle. Nature 284, 360-363.
54. Nygren A, Kondo C, Clark RB & Giles WR (2003). Voltage-sensitive dye mapping in Langendorff-perfused rat hearts. Am J Physiol Heart Circ Physiol 284, H892-H902.
55. Opie LH (1976). Effects of regional ischemia on metabolism of glucose and fatty acids. Relative rates of aerobic and anaerobic energy production during myocardial infarction and comparison with effects of anoxia. Circ Res 38, I52-I74.
56. Prasad K & MacLeod DP (1969). Influence of glucose on the transmembrane action potential of guinea-pig papillary muscle. Metabolic inhibitors, ouabain, and calcium chloride, and their interaction with glucose, sympathomimetic amines, and aminophylline. Circ Res 24, 939-950.
57. Punske BB, Ni Q, Lux RL, MacLeod RS, Ershler PR, Dustman TJ, Allison MJ & Taccardi B (2003). Spatial methods of epicardial activation time determination in normal hearts. Ann Biomed Eng 31, 781-792.
58. Qin H, Kay MW, Chattipakorn N, Redden DT, Ideker RE & Rogers JM (2003). Effects of heart isolation, voltage-sensitive dye, and electromechanical uncoupling agents on ventricular fibrillation. Am J Physiol Heart Circ Physiol 284, H1818-H1826.
59. Rett K, Wicklmayr M, Dietze GJ & Haring HU (1996). Insulin-induced glucose transporter (GLUT1 and GLUT4) translocation in cardiac muscle tissue is mimicked by bradykinin. Diabetes 45(Suppl 1), S66-S69.
60. Russell RR 3rd, Bergeron R, Shulman GI & Young LH (1999). Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol Heart Circ Physiol 277, H643-H649.
61. Russell RR 3rd, Yin R, Caplan MJ, Hu X, Ren J, Shulman GI, Sinusas AJ & Young LH (1998). Additive effects of hyperinsulinemia and ischemia on myocardial GLUT1 and GLUT4 translocation in vivo. Circulation 98, 2180-2186.
62. Saman S & Opie LH (1984). Mechanism of reduction of action potential duration of ventricular myocardium by exogenous lactate. J Mol Cell Cardiol 16, 659-662.
63. Slot JW, Geuze HJ, Gigengack S, James DE & Lienhard GE (1991). Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci U S A 88, 7815-7819.
64. Sohn K, Punske B & Sachse F (2009). Relationship between maximal upstroke velocity of transmembrane voltage and minimum time derivative of extracellular potential. In Lecture Notes in Computer Science, (Eds. Ayache, N., Delingette, H., and Sermesant, M.) Vol. 5528, pp. 505-512. Springer-Verlag, Berlin .
65. Sohn K, Sachse FB, Moreno AP, Ershler PR, Wende AR, Abel ED & Punske BB (2011). The maximal downstroke of epicardial potentials as an index of electrical activity in mouse hearts. IEEE Trans Biomed Eng 58, 3175-3183.
66. Sohn K, Sutherland D, Liang Q & Punske B (2007). Experimental measures of the minimum time derivative of the extracellular potential as an index of electrical activity during metabolic and hypoxic stress. In Lecture Notes in Computer Science, (Eds, Sachse, FB & Seemann, G) Vol. 4466, pp. 250-259. Springer-Verlag, Berlin .
67. Taegtmeyer H (1994). Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol 19, 59-113.
68. Tian R & Abel ED (2001). Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis. Circulation 103, 2961-2966.
69. Tokuno T, Watanabe M & Imaizumi Y (1999). Effects of lactate on intracellular pH and hypercontracture during simulated ischemia and reperfusion in cardiac ventricular myocytes of the guinea pig. Jpn J Pharmacol 80, 343-350.
70. 2+ exchanger activity: role of the cytoplasmic regulatory loop. J Biol Chem 283, 16505-16513.
71. Willerson JT, Scales F, Mukherjee A, Platt M, Templeton GH, Fink GS & Buja LM (1977). Abnormal myocardial fluid retention as an early manifestation of ischemic injury. Am J Pathol 87, 159-188.
72. +-ATPase in normal and ischemic porcine myocardium. J Mol Cell Cardiol 22, 1071-1082.
73. Young LH, Renfu Y, Russell R, Hu X, Caplan M, Ren J, Shulman GI & Sinusas AJ (1997). Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation 95, 415-422.